Distribution of the most common types of HPV in Iranian women with and without cervical cancer

References

• Arbyn, M., E. Weiderpass., L. Bruni, S. de Sanjosé, M. Saraiya, J. Ferlay, and F. Bray. 2020. Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis. The Lancet Global Health 8 (2):e191–e203. doi:10.1016/S2214-109X(19)30482-6.
   PubMed Web of Science ®Google Scholar
• Baseman, J. G., and L. A. Koutsky. 2005. The epidemiology of human papillomavirus infections. Journal of Clinical Virology 32:16–24. doi:10.1016/j.jcv.2004.12.008.
   PubMed Web of Science ®Google Scholar
• Berraho, M., A. Amarti-Riffi, M. El-Mzibri, R. Bezad, N. Benjaafar, A. Benideer, N. Matar, Z. Qmichou, N. Abda, M. Attaleb, et al. 2017. HPV and cofactors for invasive cervical cancer in Morocco: A multicentre case-control study. BMC Cancer. 17(1):435. doi:10.1186/s12885-017-3425-z.
   PubMed Web of Science ®Google Scholar
• Best, S. R., K. J. Niparko, and S. I. Pai. 2012. Biology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers. Otolaryngologic Clinics of North America 45 (4):807–22. doi:10.1016/j.otc.2012.04.005.
   PubMed Web of Science ®Google Scholar
• Bhargava, A., M. Shakeel, A. Srivastava, T. S. Raza., S. Rizvi, and P. Varshney. 2016. Role of human papilloma virus in oral leukoplakia. Indian Journal of Cancer 53 (1):206. doi:10.4103/0019-509X.180812.
   PubMed Web of Science ®Google Scholar
• Boda, D., A. O. Docea, D. Calina, M. A. Ilie, C. Caruntu, S. Zurac, M. Neagu, C. Constantin, D. E. Branisteanu, V. Voiculescu, et al. 2018. Human papilloma virus: Apprehending the link with carcinogenesis and unveiling new research avenues. International Journal of Oncology 52 (3):637–55.
   PubMed Web of Science ®Google Scholar
• Bray, F., J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre, and A. Jemal. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 68 (6):394–424.
   PubMed Web of Science ®Google Scholar
• Brisson, M., J. J. Kim, K. Canfell, M. Drolet, G. Gingras, E. A. Burger, D. Martin, K. T. Simms, E. Bénard, M. C. Boily, et al. 2020. Impact of HPV vaccination and cervical screening on cervical cancer elimination: A comparative modelling analysis in 78 low-income and lower-middle-income countries. The Lancet. 395(10224):575–90. doi:10.1016/S0140-6736(20)30068-4.
   PubMed Web of Science ®Google Scholar
• Chan, C. K., Aimagambetova, G., Ukybassova, T., Kongrtay, K., & Azizan, A. (2019). Human papillomavirus infection and cervical cancer: epidemiology, screening, and vaccination—review of current perspectives. Journal of Oncology, 1–11.
   Google Scholar
• Cuschieri, K., H. Cubie, M. Whitley, G. Gilkison, M. Arends, C. Graham, and E. McGoogan. 2005. Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study. Journal of Clinical Pathology 58 (9):946–50. doi:10.1136/jcp.2004.022863.
   PubMed Web of Science ®Google Scholar
• De Martel, C., M. Plummer, J. Vignat, and S. Franceschi. 2017. Worldwide burden of cancer attributable to HPV by site, country and HPV type. International Journal of Cancer 141 (4):664–70. doi:10.1002/ijc.30716.
   PubMed Web of Science ®Google Scholar
• De Sanjose, S., C. M. .Wheeler, W. G. .Quint, W. C. Hunt, N. E. Joste, L. Alemany, F. X. Bosch, E. R. Myers, and P. E. Castle. 2013. Age-specific occurrence of HPV16-and HPV18-related cervical cancer. Cancer Epidemiology and Prevention Biomarkers 22 (7):1313–18. doi:10.1158/1055-9965.EPI-13-0053.
   PubMed Web of Science ®Google Scholar
• Donne, A., L. Hampson, J. Homer, and I. N. Hampson. 2010. The role of HPV type in recurrent respiratory papillomatosis. International Journal of Pediatric Otorhinolaryngology 74 (1):7–14. doi:10.1016/j.ijporl.2009.09.004.
   PubMed Web of Science ®Google Scholar
• Ferlay, J., M. Colombet, I. Soerjomataram, T. Dyba, G. Randi, M. Bettio, A. Gavin, O. Visser, and F. Bray. 2018. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. European Journal of Cancer 103: 356–387.
   Google Scholar
• Ghittoni, R. 2015. The role of human papillomaviruses in carcinogenesis. Ecancermedicalscience 9: doi:10.3332/ecancer.2015.526.
   PubMed Web of Science ®Google Scholar
• Giuliano, A. R., G. Tortolero-Luna, E. Ferrer, A. N. Burchell, S. De. Sanjose, S. K. Kjaer, N. Muñoz, M. Schiffman, and F. X. Boschc. 2008. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine 26:K17–K28. doi:10.1016/j.vaccine.2008.06.021.
   PubMed Web of Science ®Google Scholar
• Gui, L., M. Sharma, T. Nicholas, and R. Barnabas. 2018. HIV-positive women have higher risk of HPV infection, precancerous lesions, and cervical cancer: A systematic review and meta-analysis. AIDS (London, England) 32 (6):795. doi:10.1097/QAD.0000000000001765.
   PubMed Web of Science ®Google Scholar
• Hallaji, Z., and E. Noroozi-Nejad. 2013. Genital warts in 250 Iranian patients and their high-risk sexual behaviors. Archives of Iranian Medicine 16 (9):518.
   PubMed Web of Science ®Google Scholar
• Hamkar, R., Z. Shoja, N. Ghavami, N. Heydari, M. Farahmand, and S. Jalilvand. 2017. Type-Specific Human Papillomavirus Prevalence in Iranian Women with Normal Cervical Cytology: The Impact of Current HPV Vaccines. Intervirology 60 (4):125–30. doi:10.1159/000485898.
   PubMed Web of Science ®Google Scholar
• Heard, I., L. Tondeur, L. Arowas, M. Falguières, M. C. Demazoin, M. Favre, and X. Liu. 2013. Human papillomavirus types distribution in organised cervical cancer screening in France. PloS One 8 (11):79372. doi:10.1371/journal.pone.0079372.
   PubMed Web of Science ®Google Scholar
• Houlihan, C. F., N. L. Larke, D. Watson-Jones, K. K. Smith-McCune, S. Shiboski, P. E. Gravitt, J. Smith, L. Kuhn, C. Wang, and R. Hayes. 2012. HPV infection and increased risk of HIV acquisition. A systematic review and meta-analysis. AIDS (London, England) 26 (17), 1–14. doi:10.1097/QAD.0b013e328358d908
   Web of Science ®Google Scholar
• Husain, R. A., and V. Ramakrishnan. 2015. Global variation of human papillomavirus genotypes and selected genes involved in cervical malignancies. Annals of Global Health 81 (5):675–83. doi:10.1016/j.aogh.2015.08.026.
   PubMed Web of Science ®Google Scholar
• Jamdar, F., F. Farzaneh, F. Navidpour, S. Younesi, P. Balvayeh, M. Hosseini, and R. Ghodssi-Ghasemabadi. 2018. Prevalence of human papillomavirus infection among Iranian women using COBAS HPV DNA testing. Infectious Agents and Cancer 13 (1):6. doi:10.1186/s13027-018-0178-5.
   PubMed Web of Science ®Google Scholar
• Jamshidi, M., M. Shekari, A. A. Nejatizadeh, K. Malekzadeh, M. Baghershiroodi, P. Davudian, F. Dehghan, and F. Jamshidi. 2012. The impact of human papillomavirus (HPV) types 6, 11 in women with genital warts. Archives of Gynecology and Obstetrics 286 (5):1261–67. doi:10.1007/s00404-012-2416-1.
   PubMed Web of Science ®Google Scholar
• Khodakarami, N., G. M. Clifford, P. Yavari, F. Farzaneh, S. Salehpour, N. Broutet, H. Bathija, D. A. M. Heideman, F. J. van Kemenade, C. J. L. M. Meijer, et al. 2012. Human papillomavirus infection in women with and without cervical cancer in Tehran, Iran. International Journal of Cancer. 131(2):E156–E161. doi:10.1002/ijc.26488.
   PubMed Web of Science ®Google Scholar
• Khorasanizadeh, F., J. Hassanloo, N. Khaksar, S. S. M. Taheri, M. Marzaban, B. H. Rashidi, A. Akbari Sari, and K. Zendehdel. 2013. Epidemiology of cervical cancer and human papilloma virus infection among Iranian women—Analyses of national data and systematic review of the literature. Gynecologic Oncology 128 (2):277–81. doi:10.1016/j.ygyno.2012.11.032.
   PubMed Web of Science ®Google Scholar
• Kohshour, M. O., M. Afra, A. Shakurnia, N. E. Mostofi, and B. Andashti. 2018. The Most Frequent HPV Genotypes in Women with Cervical Cancer in Southwest of Iran. Women’s Health Bulletin(In Press)
   Google Scholar
• Lin, C., J. T. F. Lau, K.-M. Ho, M.-C. Lau, H.-Y. .Tsui, and -K.-K. Lo. 2010. Incidence of genital warts among the Hong Kong general adult population. BMC Infectious Diseases 10 (1):272. doi:10.1186/1471-2334-10-272.
   PubMed Web of Science ®Google Scholar
• Ljubojević, S., J. Lipozenčić, D. L. Grgec, R. Prstačić, M. Skerlev, and Z. B. Mokos. 2008. Human papilloma virus associated with genital infection. Collegium Antropologicum 32 (3):989–97.
   PubMedGoogle Scholar
• Majidi, A., R. Ghiasvand, M. Hadji, A. Nahvijou, A. S. Mousavi, M. Pakgohar, N. Khodakarami, M. Abedini, F. A. Hashemi, F. M. R. Farzami, et al. 2016. Priority setting for improvement of cervical cancer prevention in Iran. International Journal of Health Policy and Management. 5(4):225. doi:10.15171/ijhpm.2015.201.
   Web of Science ®Google Scholar
• Melnikow, J., J. T. Henderson, B. U. Burda, C. A. Senger, S. Durbin, and M. S. Weyrich. 2018. Screening for cervical cancer with high-risk human papillomavirus testing: Updated evidence report and systematic review for the US Preventive Services Task Force. Journal of the American Medical Association 320 (7):687–705. doi:10.1001/jama.2018.10400.
   Web of Science ®Google Scholar
• Meshkat, Z., H. Soleimanjahi, M. Mahmoudi, H. Mirshahabi, Z. M. Hassan, S. R. Ghaffari, and T. Sabokbar. 2007. Determination of human papillomavirus type 16 genotype and construction of cloning vector pTZ57R encoding HPV16 E7 gene. Saudi Medical Journal 28 (10):1511–15.
   PubMed Web of Science ®Google Scholar
• Momenimovahed, Z., and H. Salehiniya. 2018. Cervical cancer in Iran: Integrative insights of epidemiological analysis. BioMedicine 8(3):18. doi:10.1051/bmdcn/2018080318.
   Google Scholar
• Mortensen, G. L., and H. K. Larsen. 2010. The quality of life of patients with genital warts: aA qualitative study. BMC Public Health 10 (1): 113.
   PubMed Web of Science ®Google Scholar
• Okunade, K. S. 2019. Human papillomavirus and cervical cancer. Journal of Obstetrics and Gynaecology 40 (5):1–7. doi:10.1080/01443615.2019.1634030.
   Web of Science ®Google Scholar
• Salehi-Vaziri, M., F. Sadeghi, F. B. Salim, S. Younesi, S. Alinaghi, S. H. Monavari, and H. Keyvani. 2015. The prevalence and genotype distribution of human papillomavirus in the genital tract of males in Iran. Jundishapur Journal of Microbiology 8 (12). doi:10.5812/jjm.21912.
   Web of Science ®Google Scholar
• Salehpour, M., N. T. Meibodi, R. Teimourpour, A. Ghorani-Azam, S. Sepahi, S. Rostami, and Z. Meshkat. 2015. Frequency of Human Papillomavirus Genotypes 6, 11, 16, 18 And 31 in Paraffin-Embedded Tissue Samples of Invasive Breast Carcinoma, North-East of Iran. Iranian Journal of Pathology 10 (3):192.
   PubMedGoogle Scholar
• Sanjosé Llongueras, S. D., B. Serrano, S. Tous, M. Alejo, B. Lloveras, B. Quirós, O. Clavero, A. Vidal, C. F. Pulido, M. Á. Pavón, et al. (2019). “Burden of human papillomavirus (HPV)-related cancers attributable to HPVs 6/11/16/18/31/33/45/52 and 58
   Google Scholar
• Scott, M., M. Nakagawa, and A. B. Moscicki. 2001. Cell-mediated immune response to human papillomavirus infection. Clinical and Diagnostic Laboratory Immunology 8 (2):209–20. doi:10.1128/CDLI.8.2.209-220.2001.
   PubMedGoogle Scholar
• Seppä, K., J. Pitkäniemi, N. Malila, and M. Hakama. 2016. Age‐related incidence of cervical cancer supports two aetiological components: A population‐based register study. BJOG: An International Journal of Obstetrics & Gynaecology 123 (5):772–78.
   PubMed Web of Science ®Google Scholar
• Skroumpelos, A., T. Agorastos, T. Constantinidis, K. Chatzistamatiou, J. Kyriopoulos, and S. K. Lhachimi. 2019. Economic evaluation of HPV DNA test as primary screening method for cervical cancer: A health policy discussion in Greece. PloS One 14 (12):12. doi:10.1371/journal.pone.0226335.
   Web of Science ®Google Scholar
• Sohrabi, A., M. Hajia, F. Jamali, and F. Kharazi. 2017. Is incidence of multiple HPV genotypes rising in genital infections? Journal of Infection and Public Health 10 (6):730–33. doi:10.1016/j.jiph.2016.10.006.
   PubMed Web of Science ®Google Scholar
• Sundström, K., A. Ploner, L. Arnheim-Dahlström, S. Eloranta, J. Palmgren, H. O. Adami, Y. N. Helm, P. Sparén, and J. Dillner. 2015. Interactions between high-and low-risk HPV types reduce the risk of squamous cervical cancer. Journal of the National Cancer Institute 107 (10):djv185.
   Google Scholar
• Taheri, N., A. Fazel, H. Mahmoodzadeh, R. Omranpour, G. Roshandel, S. Gharahjeh, S. M. Sedaghat, M. Poorabbasi, A. Moghaddami, and S. Semnani. 2014. Epidemiology of female reproductive cancers in Iran: Results of the Gholestan Population-based Cancer Registry. Asian Pacific Journal of Cancer Prevention 15 (20):8779–82. doi:10.7314/APJCP.2014.15.20.8779.
   PubMedGoogle Scholar
• Tempfer, C., C. Grimm, C. Harwanegg, M. Huber, M. W. Mueller, B. Buerkle, A. Reinthaller, and L. A. Hefler. 2007. Frequency of 23 human papillomavirus types using DNA microarray in women with and without cytological anomalies. Anticancer Research 27 (3B):1721–26.
   PubMed Web of Science ®Google Scholar
• Venceslau, E. M., M. M. Bezerra, A. C. M. Lopes, É. V. Souza, A. S. C. Onofre, C. M. D. Melo, V. D. L. S. Jeraldo, and F. B. D. M. Onofre. 2014. HPV detection using primers MY09/MY11 and GP5+/GP6+ in patients with cytologic and/or colposcopic changes. Jornal Brasileiro De Patologia E Medicina Laboratorial 50 (4):280–85. doi:10.5935/1676-2444.20140028.
   Google Scholar
• WHO. 2002. Cervical cancer screening in developing countries: report of a WHO consultation.
   Google Scholar
• Yaghoubi, M., M. Nojomi, A. Vaezi, V. Erfani, S. Mahmoudi, K. Ezoji, S. M. Zahraei, I. Chaudhri, and M. Moradi-Lakeh. 2018. Cost-Effectiveness Analysis of the Introduction of HPV Vaccination of 9-Year-Old-Girls in Iran. Value in Health Regional Issues 15:112–19. doi:10.1016/j.vhri.2018.03.001.
   PubMedGoogle Scholar
• Zafari, E., H. Soleimanjahi, S. Samiee, H. Razavinikoo, and Z. Farahmand. 2018. Comparison of methylation patterns of E6 gene promoter region in the low-risk and high-risk human papillomavirus. Iranian Journal of Microbiology 10 (6):441.
   PubMed Web of Science ®Google Scholar
• Zeng, Z., H. Yang, Z. Li, X. He, C. C. Griffith, X. Chen, X. Guo, B. Zheng, S. Wu, and C. Zhao. 2016. Prevalence and genotype distribution of HPV infection in China: Analysis of 51,345 HPV genotyping results from China’s largest CAP certified laboratory. Journal of Cancer 7 (9):1037. doi:10.7150/jca.14971.
   PubMed Web of Science ®Google Scholar
• Zhao, J., W. Zeng, Y. Cao, X. Liang, and B. Huang. 2014. Immunotherapy of HPV infection-caused genital warts using low dose cyclophosphamide. Expert Review of Clinical Immunology 10 (6):791–99. doi:10.1586/1744666X.2014.907743.
   PubMed Web of Science ®Google Scholar